1. Home
  2. ELVN vs PSFE Comparison

ELVN vs PSFE Comparison

Compare ELVN & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • PSFE
  • Stock Information
  • Founded
  • ELVN 2016
  • PSFE 1996
  • Country
  • ELVN United States
  • PSFE United Kingdom
  • Employees
  • ELVN N/A
  • PSFE N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • PSFE Business Services
  • Sector
  • ELVN Health Care
  • PSFE Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • PSFE Nasdaq
  • Market Cap
  • ELVN 927.8M
  • PSFE 856.2M
  • IPO Year
  • ELVN 2020
  • PSFE N/A
  • Fundamental
  • Price
  • ELVN $18.42
  • PSFE $15.41
  • Analyst Decision
  • ELVN Strong Buy
  • PSFE Sell
  • Analyst Count
  • ELVN 4
  • PSFE 4
  • Target Price
  • ELVN $39.25
  • PSFE $17.38
  • AVG Volume (30 Days)
  • ELVN 260.6K
  • PSFE 218.9K
  • Earning Date
  • ELVN 05-13-2025
  • PSFE 05-13-2025
  • Dividend Yield
  • ELVN N/A
  • PSFE N/A
  • EPS Growth
  • ELVN N/A
  • PSFE N/A
  • EPS
  • ELVN N/A
  • PSFE 0.36
  • Revenue
  • ELVN N/A
  • PSFE $1,704,835,000.00
  • Revenue This Year
  • ELVN N/A
  • PSFE $2.83
  • Revenue Next Year
  • ELVN N/A
  • PSFE $6.27
  • P/E Ratio
  • ELVN N/A
  • PSFE $42.92
  • Revenue Growth
  • ELVN N/A
  • PSFE 6.48
  • 52 Week Low
  • ELVN $13.30
  • PSFE $13.01
  • 52 Week High
  • ELVN $30.03
  • PSFE $26.25
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 47.86
  • PSFE 50.87
  • Support Level
  • ELVN $17.76
  • PSFE $14.78
  • Resistance Level
  • ELVN $20.79
  • PSFE $16.07
  • Average True Range (ATR)
  • ELVN 1.37
  • PSFE 0.54
  • MACD
  • ELVN 0.12
  • PSFE 0.11
  • Stochastic Oscillator
  • ELVN 45.39
  • PSFE 72.84

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About PSFE Paysafe Limited

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

Share on Social Networks: